Antioxidant treatment with carnitines is effective in infertile patients with prostatovesiculoepididymitis and elevated seminal leukocyte concentrations after treatment with nonsteroidal anti-inflammatory compounds

Fertil Steril. 2002 Dec;78(6):1203-8. doi: 10.1016/s0015-0282(02)04350-9.

Abstract

Objective: To evaluate whether the association of antioxidants and anti-inflammatory compounds may be beneficial in treatment of patients with abacterial prostatovesiculoepididymitis (PVE) and elevated seminal leukocyte concentrations.

Design: Open, prospective, random study.

Setting: Academic research environment.

Patient(s): Ninety-eight patients with PVE who had increased seminal leukocyte concentrations (>1 x 10(6) cells/mL). Carnitines (group A; n = 30) or nonsteroidal anti-inflammatory drugs (group B; n = 16) for 4 months; nonsteroidal anti-inflammatory drugs for 2 months, followed by treatment with carnitines for 2 months (group C; n = 26); or nonsteroidal anti-inflammatory treatment given concomitantly with carnitines (group D; n = 26) for 4 months.

Main outcome measure(s): Semen variables, production of reactive oxygen species, and pregnancy outcome were evaluated before and after treatment and following a 3-month washout period.

Result(s): Patients in group C had the highest reduction in production of reactive oxygen species associated with increased sperm motility and viability. Groups B and D experienced intermediate effects, and group A experienced the least effect.

Conclusion(s): Antioxidant treatment with carnitines is effective in patients with abacterial PVE and increased seminal leukocyte concentrations if these patients have been pretreated with nonsteroidal anti-inflammatory drugs.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Antioxidants / therapeutic use*
  • Carnitine / therapeutic use*
  • Epididymitis / complications
  • Epididymitis / drug therapy*
  • Female
  • Genital Diseases, Male / drug therapy*
  • Humans
  • Infertility, Male / etiology*
  • Infertility, Male / pathology
  • Inflammation / complications
  • Inflammation / drug therapy
  • Leukocytes / pathology
  • Male
  • Pregnancy
  • Pregnancy Rate
  • Prospective Studies
  • Prostatitis / complications
  • Prostatitis / drug therapy*
  • Reactive Oxygen Species / antagonists & inhibitors
  • Semen / cytology
  • Seminal Vesicles* / drug effects

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Antioxidants
  • Reactive Oxygen Species
  • Carnitine